No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MOH240621P185000
- 0.90
- 0.000.00%
15min DelayClose Jun 12 15:52 ET
0.00High0.00Low
0.90Open0.90Pre Close0 Volume3 Open Interest185.00Strike Price0.00Turnover176.92%IV39.61%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.90Extrinsic Value100Contract SizeAmericanOptions Type-0.0255Delta0.0007Gamma338.71Leverage Ratio-0.2619Theta-0.0019Rho-8.65Eff Leverage0.0283Vega
Intraday
- 5D
- 1D
News
Molina Healthcare, Inc. (NYSE:MOH) Could Be Riskier Than It Looks
It's not a stretch to say that Molina Healthcare, Inc.'s (NYSE:MOH) price-to-earnings (or "P/E") ratio of 17.1x right now seems quite "middle-of-the-road" compared to the market in the United States,
Molina Healthcare Donates West Louisville Property to Jefferson County Public Schools for New Middle School
Molina Healthcare ("Molina" or "Company") today announced it will donate its 20-acre property in Louisville at 18th and Broadway to Jefferson County Public Schools ("JCPS"). JCPS plans to build a new middle school at
Press Release: Molina Healthcare Announces Second Quarter 2024 Earnings Release and Conference Call Dates
Molina Healthcare Announces Second Quarter 2024 Earnings Release and Conference Call Dates LONG BEACH, Calif.--(BUSINESS WIRE)--June 05, 2024-- Molina Healthcare, Inc. (NYSE: MOH) today announced it
Wells Fargo Maintains Molina Healthcare(MOH.US) With Hold Rating, Maintains Target Price $375
Wells Fargo analyst Steve Baxter maintains $Molina Healthcare(MOH.US)$ with a hold rating, and maintains the target price at $375.According to TipRanks data, the analyst has a success rate of 56.5% an
Molina Healthcare Announces Second Quarter 2024 Earnings Release and Conference Call Dates
PDF Version LONG BEACH, Calif.--(BUSINESS WIRE)--Jun. 5, 2024-- Molina Healthcare, Inc. (NYSE: MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2024, a
Here's How Much You Would Have Made Owning Molina Healthcare Stock In The Last 10 Years
Molina Healthcare (NYSE:MOH) has outperformed the market over the past 10 years by 10.98% on an annualized basis producing an average annual return of 21.42%. Currently, Molina Healthcare has a market
Comments
The 13F filing for the hedge fund led by the late Jim Simons (RIP) just dropped and we got you covered
Here's a breakdown of the biggest moves:
🔴 SOLD (ranked by largest prev. portfolio %)
$Exxon Mobil(XOM.US$ : 0.70%
$Boeing(BA.US$ : 0.43%
$GE Aerospace(GE.US$ : 0.41%
$Alphabet-C(GOOG.US$ : 0.31%
$Netflix(NFLX.US$ : 0.31%
$Disney(DIS.US$ : 0.24%
🟢 NEW (ranked by portfolio %):
$Chevron(CVX.US$ : 0.52% ...
Here's a breakdown of the biggest moves:
🔴 SOLD (ranked by largest prev. portfolio %)
$Exxon Mobil(XOM.US$ : 0.70%
$Boeing(BA.US$ : 0.43%
$GE Aerospace(GE.US$ : 0.41%
$Alphabet-C(GOOG.US$ : 0.31%
$Netflix(NFLX.US$ : 0.31%
$Disney(DIS.US$ : 0.24%
🟢 NEW (ranked by portfolio %):
$Chevron(CVX.US$ : 0.52% ...
+1
18
RECAP
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
42
4
Recent insider selling at Molina Healthcare may hint at insiders believing the shares are overpriced. Despite profitability and profit growth, the absence of insider buying and recent selling could caution investors.
Analysts' sentiment remains steady post latest results, with a minor rise in revenue forecasts. Despite EPS missing estimates, earnings continue to be the value driver. Molina Healthcare's revenue growth rate is expected to surpass the industry.
1
Molina Healthcare's high P/E ratio is justified by its strong forecast growth, surpassing the wider market. Investors see insignificant potential for earnings deterioration, hence a lower P/E ratio isn't warranted. Share price drop in near future is unlikely.
Read more